Tiziana Life Sciences Ltd. Common Shares Stock Prediction
AI-powered sentiment analysis and prediction trends for TLSA, updated each market day.
TLSA AI Sentiment
AI sees no strong directional signal for Tiziana Life Sciences Ltd. Common Shares stock over the next 10 market days.
Prediction date: May 20, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Tiziana Life Sciences Ltd. Common Shares
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. The company's clinical pipeline includes drug assets for Non-Active Secondary Progressive Multiple Sclerosis, Multiple System Atrophy, Alzheimer's, and Amyotrophic Lateral Sclerosis. The company's mission is to design and deliver next-generation immunotherapies for neurodegenerative and neuroinflammatory diseases. The company's main immunotherapeutic candidate, Foralumab (TZLS-401), is being developed for Non-Active Secondary Progressive Multiple Sclerosis, Alzheimer's, and other CNS indications.
Exchange
Market Cap
$184,525,739
Cap Tier
Employees
10
Listed Since
Nov. 20, 2018
TLSA Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
TLSA Volatility
Tiziana Life Sciences Ltd. Common Shares has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
